Further processing options
A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia
Saved in:
Journal Title: | Cancer Science |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , |
In: | Cancer Science, 111, 2020, 9, p. 3327-3337 |
Type of Resource: | E-Article |
Language: | English |
published: |
Wiley
|
Subjects: |